Evidence map›Paper›PMID 39465195›Full record

ArticleThe Pan African medical journal2024

Epidemiological profile of visceral leishmaniasis in northern Morocco (2009-2018).

Kaoutar Nabah, Nadya Mezzoug, Halima Oufdou, Kacem Rharrabe

Abstract read
In one paragraph

Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kaoutar NabahLaboratory of Biology, Environment and Sustainable Development, Higher Normal School, Abdelmalek Essaadi University, Tetouan, Morocco.
Nadya MezzougLaboratory of Chemistry Applied Microbiology and Biotechnology, Faculty of Sciences, Abdelmalek Essaadi University, Tetouan, Morocco.
Halima OufdouLaboratory of Applied Economics, Faculty of Economic and Social Legal Sciences, Mohammed V University, Rabat, Morocco.
Kacem RharrabeLaboratory of Biology, Environment and Sustainable Development, Higher Normal School, Abdelmalek Essaadi University, Tetouan, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: visceral leishmaniasis (VL) represents the most serious and severe form of leishmaniasis in Northern Morocco. In this context, the objective of this study was to describe the epidemiological profile of VL in the Tangier Tetouan Al-Hoceima region from 2009 to 2018. Methods: the epidemiologic data was collected from April 28 Results: the study included 304 cases. Chefchaouen province was the highest endemic area (54.5%). The cases in the spring reached 36.5% and were characterized by age ≤5 years old (78.8%), male gender (M/F=1.3) and rural residents (91.4%). The number of inhabitants per household of cases was >5 persons (68.5%). A total of 94.3% and 98% had no suspect cases around or in their homes, respectively. Farmers accounted for 74.5% of cases. Signs of fever were present in 17.4% of cases, with 67.3% of these cases presenting these signs for a duration of more than 30 days. A total of 64.2% cases were diagnosed within a month. The serological test was used for diagnosis in 67.1% of cases and for the treatment, glunantime® was used in all cases (100%). Conclusion: to eliminate the VL infection, it's necessary to monitor the entomological, mammalogical investigation. Also, to activate the Integrated Vector Control Management Committee at the most endemic province and to inform the community as well as the professionals of health about the VL control measures. A correlational study of the VL socio-economic and climate factors is recommended.

Indexed as

Leishmaniasis, VisceralAdolescentAdultAgedChildChild, PreschoolFemaleFeverHumansInfantMaleMiddle AgedMoroccoRural PopulationSeasonsYoung AdultEpidemiologyMorocconeglected tropical diseasevisceral leishmaniasis

Identifiers

PMID39465195
PMCPMC11512148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.